Responses
Regular and Young Investigator Award Abstracts
Cell Therapies
361 Universal expansion of CBL-B-inhibited tumor infiltrating lymphocytes, DeTIL-0255, from women with ovarian cancer: Process validation
Compose a Response to This Article
Other responses
No responses have been published for this article.